Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin
NCT00831571
·
clinicaltrials.gov ↗
COMPLETED
Status
112
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Esophageal Cancer
Gastric Cancer
Small Bowel Cancer
Pancreatic Cancer
Sponsor
Dana-Farber Cancer Institute
Collaborators
[object Object]